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2. The personnel associated with this project will remain virtually the same as 
last year. Mrs. Laura Landgraff has completed her Master's degree and will no 
longer be associated with this project. Dr. Robert Phillips has completed his 
Ph.D. working with protocatechuate-3,-4-dioxygenase, and will continue to work 
part time on this project. 
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3. PROGRESS REPORT 
Objectives. Non-heme iron containing oxygenases have been shown to be involved in a 
large number of metabolic processes in both mamalian and bacterial systems. The goal 
of our research program is to analyze the involvement of non-heme iron in the catalytic 
pathway of a selected oxygenase. Particular attention is to be paid to the possibility 
of changes in coordination geometry during catalysis, to the relationship between the 
substrate binding site and the metal ion, to the factors which influence substrate 
binding and to the possible role of protein functional groups in catalysis. Of par-
ticular significance, we wish to evaluate fluorine-containing substrate analogs as 
potential specific and effective oxygenase inhibitors which should be highly useful 
active-site probes. Hopefully, the results obtained will alow for the design of similar 
compounds potentially useful as specific oxygenase inhibitors for use in the clinical 
treatment of disease. 
Isolation of Protocatechuate-3,4-Dioxygenase and Syntheses of Active-Site Directed Sub-
strate Analogs. These operations are now carried out routinely using the procedures we 
developed during the first year of the project as described in last year's report.' 
Resonance Raman Spectroscopic Studies. Our goals for this'year were to complete the 
resonance Raman spectroscopic studies on both PCD and its E•S and E•I complexes in col-
laboration with Dr. R. H. Felton of this department. We have previously demonstrated 
that 3-halo-4-hydroxybenzoates such as 3-FHB and 3-C1HB are potent inhibitors and 
active-site titrants which exhibit simple kinetic and spectral properties, and our 
comparative studies with 3- and 4-substituted hydroxybenzoates established the critical 
role of the 4-hydroxl substituents in binding. Insight into the molecular details of 
metal participation in these binding interactions has now been provided by our resonance 
Raman studies on resting PCD and both the E.S and E-I complexes. We have demonstrated 
that the iron atom in PCD is tyrosine ligated, an observation now confirmed in two other 
laboratories and consistent with CD studies and we have been able to estimate that, in 
fact, two tyrosines are involved in iron coordination. In the E•I complexes with the 
3-halohydroxybenzoates, our data establish that inhibitor interacts with the metal atom 
via Fe-0 ligation without displacing either tyrosine, thus clarifying the critical need 
for a p-hydroxyl substituent for potent binding. In the case of substrate, the stable 
E•S species observed anaerobically in our Raman studies exhibits iron chelation by the 
o-dihydroxy grouping, again with neither tyrosine ligand being displaced. In all 
probability, the carboxylate functionality of both substrate and inhibitors ionically 
interacts with a cationic group, likely an arginine [by analogy with p-hydroxybenzoate 
hydroxylase] or possibly a lysine. Thus,resonance Raman has provided an unambiguous 
molecular -level picture of the active-site region of PCD and the changes which occur 
upon substrate and inhibitor binding. During the coming year, we wish to extend these 
Raman studies to the mechanistically significant ternary E•S•02 complex which has been 
implicated as an obligatory intermediate in catalysis. 
Our Raman data have also suggested the intriguing possibility that there is a sulfhydryl 
ligand to the iron atom, which is displaced upon inhibitor binding. The existence of 
such a sulfhydryl ligand is reminiscent of the situation in P-450, but here the iron 
atom is in an entirely difference coordination environment. We plan to follow up on this 
suggestion by carrying out further spectroscopic studies as well as specific chemical 
modification work coupled with reconstitution experiments. In this regard, the availi-
bility in our hands of iron, cobalt-substituted and specifically thiol-modified rubre-
doxin is of critical importance [see Biochemistry,  17, 3333 (1978)]. 
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3. Progress Report (continued) 
Kinetic Studies of Inhibitor and Substrate Binding and Catalytic Turnover. In a 
series of experiments which beautifully complement the Raman, we have completed both 
steady state and rapid reaction kinetic studies on inhibitor and substrate binding 
and on catalytic turnover. We have previously shown that the E•I complexes of all inhi-
bitors containing 4-0H substitutents exhibit virtually identical spectral features. Thus, 
at first glance it seems natural to conclude that the increase inhibitory potency caused 
by 3-halo substitution is attributable to the greatly increased acidity of the p-hydroxyl. 
Our kinetic data establish that prior ionization is not, in fact, responsible for this 
increase binding potency, and furthermore, that the ionization effects on substrate and 
inhibitor association rate constants are very similar. It seems reasonable to assume 
that the monodentate Fe-0 ligation which we see in the Raman of E•I also occurs for 
substrate on the pathway toward chelation, the stable state actually seen in the Raman 
studies on the E•S complex. Thus, we conclude that the active site of PCD is set up 
to provide for facile removal of the proton from even a non-acidic p-hydroxyl such as 
those found in all known PCD substrates. This could be accomplished by the presence of 
a base (e.g. a histidine),which picks up the proton as the hydroxyl nears the coordin-
ation sphere of the iron, effectively lowering its pK a . This picture, explains why PCD 
readily accomodates either the protonated or anionic forms of the halohydroxybenzoates, 
and in order to accomdate the kinetic and spectral data, we conclude that the ionization 
state of this base has a negligible effect on either the spectral or kinetic properties 
of the E•I complex. A strikingly similar conclusion has very recently been reached 
regarding p-hydroxybenzoate hydroxylase. Our data on inhibitor binding clearly reveals 
a high sensitivity to the steric requirements of the substitutents at position 3 and a 
linear free energy plot shows a very good correlation with steric substituent constants. 
To further elucidate the action of PCD with inhibitor, dissociation rates were measured 
via stopped-flow double displacement experiments on several classes of inhibitors. The 
results are not discussed here in detail, but fully corraborate the picture of inhibitor 
binding at the PCD active site just described. 
We have also completed a detailed study of ionization effects on the breakdown of E•S•0 2 , 
and have demonstrated that a simple ionization of pk 7 facilitates this process. In a 
manuscript which has been submitted for publication we discuss this finding in terms of 
currently thinking about the mechanism of action of dixoygenases such as PCD. 
In summary, we have used kinetic and spectroscopic techniques to amplify on the molecular-
level picture of binding at the active site of PCD provided by our Raman work. In 
addition, the kinetic results have provided insights into the detailed mechanism of 
oxygen insertion catalyzed by this non-heme iron containing dioxygenase. During the 
coming year, our goals are to focus further on the coordination environment of the metal 
with particular attention to the possibility of a sulfhydryl ligand and to utilize 
both spectroscopic and kinetic techniques to elucidate the structure of the catalytically 
competent E•S•02 complex, thus providing molecular-level detail about the mechanism of 
non-heme iron dioxygenase catalysis. 
Significance. It is our contention that information of the type which we are attempting 
II to obtain with PCD is highly significant. As such information becomes available for non-heme oxygenases, it will serve as the basis for the design of oxygenase inhibitors and/or activators for possible in vivo applications similar to those currently being pursued with other types of enzymes (e.g. proteases). We feel that our work with 
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1 3. Progress Report (continued) 
the fluoro-substituted substrate analogs is especially significant in this regard 
since it establishes the potential of such compounds as highly potent oxygenase inhi- 
bitors. Second generation effectors can now be designed, and we anticipate incorporating 
reactive chemical functionalities into such substances so as to render them irreversible 
or "suicide" effectors for various oxygenases. Even if the particular compounds we are 
now examing never prove directly useful in clinical applications, they will be exceedingly 
useful tools for the study of the role of oxygenases in biological processes. Thus, if 
such compounds only establish a general approach for affecting disease-related oxy- 
gnease enzymes, they will represent a major step forward towards the eventual design of 
clinically useful compounds. 
The undersigned agrees to accept responsiblity for the scientific and technical conduct 
of the project and for the provision of the required progress reports if a grant is 
awarded as a result of this application. 
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